CS logo
small CS logo
The University of Hong Kong/Queen Mary Hospital

Hong Kong, Hong Kong, China, Hong Kong
位於香港的醫院

About The University of Hong Kong/Queen Mary Hospital


瑪麗醫院是一所位於香港香港島南區西高山的大型公立綜合醫院,並提供24小時急症服務,也是香港兩所教學醫院之一,為香港大學醫學院教學醫院。該院於於1937年4月13日啟用,是當時香港以至遠東地區規模最大的醫院之一。醫院以英皇佐治五世皇后特克的瑪麗命名。
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at The University of Hong Kong/Queen Mary Hospital


During the past decade, The University of Hong Kong/Queen Mary Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "The University of Hong Kong/Queen Mary Hospital" #1 collaborator was "Food and Health Bureau, Hong Kong" with 1 trials as a collaborator and "Research Grant Council" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at The University of Hong Kong/Queen Mary Hospital


According to Clinical.Site data, the most researched conditions in "The University of Hong Kong/Queen Mary Hospital" are "Chronic Hepatitis b" (1 trials), "Cirrhosis" (1 trials), "Empagliflozin" (1 trials), "Fibrosis, Liver" (1 trials) and "NAFLD" (1 trials). Many other conditions were trialed in "The University of Hong Kong/Queen Mary Hospital" in a lesser frequency.

Clinical Trials Intervention Types at The University of Hong Kong/Queen Mary Hospital


Most popular intervention types in "The University of Hong Kong/Queen Mary Hospital" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Empagliflozin 10 MG" (2 trials) and "Placebo pills" (2 trials). Other intervention names were less common.

Clinical Trials Genders at The University of Hong Kong/Queen Mary Hospital


The vast majority of trials in "The University of Hong Kong/Queen Mary Hospital" are 2 trials for "All" genders.

Clinical Trials Status at The University of Hong Kong/Queen Mary Hospital


Currently, there are NaN active trials in "The University of Hong Kong/Queen Mary Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in The University of Hong Kong/Queen Mary Hospital, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in The University of Hong Kong/Queen Mary Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".